[an error occurred while processing this directive]
临床研究

单中心腹膜透析患者隧道感染的临床特征和治疗效果

  • 田秀娟 ,
  • 许国双
展开
  • 1空军军医大学第一附属医院肾脏内科

收稿日期: 2021-02-18

  修回日期: 2021-05-07

  网络出版日期: 2021-07-21

Clinical characteristics and treatment of catheter-related tunnel infection in peritoneal dialysis patients: the results from a singlEcentered study

  • TIAN Xiu-Juan ,
  • XU Guo-Shuang
Expand
  • 1 Department of Nephrology, the First Affiliated Hospital, Airforce Military University, Xi’an , Shanxi 710032, P. R. China

Received date: 2021-02-18

  Revised date: 2021-05-07

  Online published: 2021-07-21

摘要

【摘要】目的探讨腹膜透析患者隧道感染(tunnel infection ,TI)的流行病学特征和临床转归。方法回顾性分析空军军医大学第一附属医院2010~2020 年确诊的TI 合并/不合并出口部位感染、腹膜炎患者基线特征、致病微生物及药敏/耐药特点、治疗效果。结果3 6 名腹膜透析患者发生41 次TI ,男性2 8 例,女性8 例,平均年龄( 41.44±13.75)岁,发病率为1 次每278 患者月。14 例行超声检查,其中11 例在外cuff 周围有明确的透明带,透明带厚度平均为(2.89±1.97)mm。致病微生物培养阳性率为68.3%(28/41),以革兰氏阳性菌为主( 75. 0 % ) ,尤其是金黄色葡萄球菌( 60 . 7% )。入院后给予聚维酮碘清洁出口,经验性庆大霉素隧道口滴注、莫匹罗星软膏局部治疗,后根据培养基药敏结果调整用药,总治愈率为85 .4 % ,经验性治疗治愈率为63. 4 % ,4 例( 9 .8 % )因难治性TI 拔除腹膜透析导管,1 例( 2. 4 % )因导管相关性腹膜炎死亡。结论TI 是腹膜透析的常见并发症之一。良好的培训计划、导管出口部位护理是预防TI 的关键措施。超声检查是诊断隧道感染的有效辅助工具,革兰氏阳性菌是隧道感染的主要病因。多数患者积极治疗可延长了导管存活时间。

本文引用格式

田秀娟 , 许国双 . 单中心腹膜透析患者隧道感染的临床特征和治疗效果[J]. 中国血液净化, 2021 , 20(07) : 469 -472 . DOI: 10.3969/j.issn.1671-4091.2021.07.009

Abstract

【Abstract】Objective To investigate the epidemiology and clinical outcome of catheter-related tunnel infection (TI) in peritoneal dialysis (PD) patients. Methods The PD patients with and without TI and peritonitis identified during 2010-2021 in Xijing Hospital were retrospectively studied. Their baseline characteristics, pathogenic microorganisms, antibiotics susceptibility/resistance and treatment outcome were analyzed. Results A total of 41 TI episodes happened in 36 PD patients, of which 28 were males and 8 were females with an average age of 41.44±13.75 years. The incidence rate of TI was once every 278 patient months. Ultrasonography was conducted in 14 patients, of which 11 cases were found to have defined sonolucent zones around the outer cuffs with an average thickness of 2.89±1.97mm. Pathogenic microorganism culture was positive in 68.3% samples, in which 75.0% were Gram positive bacteria, especially Staphylococcus aureus (60.7%). After admission, the patients were empirically given gentamicin drip at the entrance of the tunnel and local treatment with Mupirocin ointment, and then the treatment was adjusted according to the results of drug sensitivity of the pathogens. The total cure rate was 85.4%, including the empirical cure rate of 63.4%. Catheter removal was required in 4 (9.8%) patients, and one patient (2.4%) died of catheter-related peritonitis. Conclusions TI is one of the common complications of PD. Better PD training program and nursing care of the catheter exit are the key measures to prevent TI. Ultrasonography of the tunnel sites is an effective tool for the diagnosis of TI. Gram-positive organisms are the major pathogens of the infections. Active treatment can extend the survival time of the catheter in most PD patients.

参考文献

参考文献
[1] Scalamogna A, De Vecchi A, Castelnovo C, et al. Long-term incidence of peritonitis in CAPD patients treated by the Y set technique: experience in a single center[J]. Nephron, 1990,55(1):24-27.
[2] Flanigan M, Gokal R. Peritoneal catheters and exit-site practices toward optimum peritoneal access: a review of current developments[J]. Perit Dial Int, 2005,25(2):132-139.
[3] Figueiredo AE, Bernardini J, Bowes E, et al. A Syllabus for Teaching Peritoneal Dialysis to Patients and Caregivers[J]. Perit Dial Int, 2016,36(6):592-605.
[4] Szeto CC, Li PK, Johnson DW, et al. ISPD Catheter-Related Infection Recommendations: 2017 Update[J]. Perit Dial Int, 2017,37(2):141-154.
[5] Marzuk SM, Rohit A, Nagarajan P, et al. An unusual case of unresolving tunnel infection in a patient on continuous ambulatory peritoneal dialysis[J]. Indian J Med Microbiol, 2018,36(4):600-602.
[6] Santos C, Pérez-Fontán M, Rodríguez-Carmona A, et al. Identification of Targets for Prevention of Peritoneal Catheter Tunnel and Exit-Site Infections in Low Incidence Settings[J]. Perit Dial Int, 2016,36(1):43-51.
[7] Rodríguez-Carmona A, Pérez-Fontán M, López-Mu?iz A, et al. Correlation between glycemic control and the incidence of peritoneal and catheter tunnel and exit-site infections in diabetic patients undergoing peritoneal dialysis[J]. Perit Dial Int, 2014,34(6):618-626.
[8] Plum J, Sudkamp S, Grabensee B. Results of ultrasound-assisted diagnosis of tunnel infections in continuous ambulatory peritoneal dialysis[J]. Am J Kidney Dis, 1994,23(1):99-104.
[9] Kwan TH, Tong MK, Siu YP, et al. Ultrasonography in the management of exit site infections in peritoneal dialysis patients[J]. Nephrology (Carlton), 2004,9(6):348-352.
[10] Nardelli L, Scalamogna A, Messa P. The impact of the superficial cuff position on the exit site and tunnel infections in CAPD patients[J]. J Nephrol, 2020
[11] Nozaki K, Kamijo Y, Nakatsuka M, et al. Computed tomography for the management of?exit-site and tunnel infections in peritoneal dialysis patients?[J]. Clin Nephrol, 2016,86 (2016)(12):328-332.
[12] Xie H, Zhang W, Cheng J, et al. Laparoscopic versus open catheter placement in peritoneal dialysis patients: a systematic review and meta-analysis[J]. BMC Nephrol, 2012,13:69.
[13] Chula DC, Campos RP, de Alcantara MT, et al. Percutaneous and surgical insertion of peritoneal catheter in patients starting in chronic dialysis therapy: a comparative study[J]. Semin Dial, 2014,27(3):E32-37.
[14] Sun C, Zhang M, Jiang C. Vertical Tunnel-based Low-site Peritoneal Dialysis Catheter Implantation Decreases the Incidence of Catheter Malfunction[J]. Am Surg, 2015,81(11):1157-1162.
[15] Ejlersen E, Steven K, L?kkegaard H. Paramedian versus midline incision for the insertion of permanent peritoneal dialysis catheters. A randomized clinical trial[J]. Scand J Urol Nephrol, 1990,24(2):151-154.
[16] Mori T, Sato S, Oba-Yabana I, et al. Better Healing of the Exit Site with Negative-Pressure Wound Therapy[J]. Adv Perit Dial, 2018,34(2018):53-57.
[17] Mushahar L, Mei LW, Yusuf WS, et al. Exit-Site Dressing and Infection in Peritoneal Dialysis: A Randomized Controlled Pilot Trial[J]. Perit Dial Int, 2016,36(2):135-139.
[18] Szeto CC, Li PK. Peritoneal Dialysis-Associated Peritonitis[J]. Clin J Am Soc Nephrol, 2019,14(7):1100-1105.
[19] Thokhonelidze I, Maglakelidze N, Sarishvili N, et al. Single center experience in successful prevention of exit-site infection in patients on peritoneal dialysis[J]. Georgian Med News, 2015(241):54-58.
[20] Lew SQ, Gruia A. Ofloxacin solution for persistent exit-site and tunnel infection in peritoneal dialysis[J]. Perit Dial Int, 2013,33(1):101-102.
[21] Jhawar MS, Das J, George P, et al. CAPD Catheter Exit-Site and Tunnel Infection with Fungal Etiology-Treatment and Catheter Reinsertion for an Extremely Rare Complication[J]. Perit Dial Int, 2017,37(2):237-239.
[22] Fukasawa M, Matsushita K, Tanabe N, et al. A novel salvage technique that does not require catheter removal for exit-site infection[J]. Perit Dial Int, 2002,22(5):618-621.
[23] Debowski JA, W?rp C, Kjellevold SA, et al. Cuff extrusion in peritoneal dialysis: single-centre experience with the cuff-shaving procedure in five patients over a 4-year period[J]. Clin Kidney J, 2017,10(1):131-134.
[24] Kirmizis D, Bowes E, Ansari B, et al. Exit-Site Relocation: A Novel, Straightforward Technique for Exit-Site Infections[J]. Perit Dial Int, 2019,39(4):350-355.
[25] Meng C, Beco A, Oliveira A, et al. Peritoneal Dialysis Cuff-Shaving-A Salvage Therapy for Refractory Exit-Site Infections[J]. Perit Dial Int, 2019,39(3):276-281.
[26] Akoh JA. Peritoneal dialysis associated infections: An update on diagnosis and management[J]. World J Nephrol, 2012,1(4):106-122.
[27] Russo R, Manili L, Tiraboschi G, et al. Patient re-training in peritoneal dialysis: why and when it is needed[J]. Kidney Int Suppl, 2006(103):S127-132.
[28] Bordin G, Casati M, Sicolo N, et al. Patient education in peritoneal dialysis: an observational study in Italy[J]. J Ren Care, 2007,33(4):165-171.
文章导航

/

[an error occurred while processing this directive]